ACCEPTANCE OF SWITCH, PATIENT SATISFACTION AND ADVERSE EVENTS AFTER SWITCH FROM ADALIMUMAB ORIGINATOR TO BIOSIMILAR SB5 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN A REAL-LIFE SETTING

Thomas De Somer  1     Didier Baert  1     Mieke Deceuninck  2     Inge Huys  1     Veerle Mattens  3     An Sterckx  3     Erik Vanderstraeten  1     Jo Vandervoort  3     Nina Van Heddegem  1     Pieter Dewint  4     Nele Deprez     Stijn Vanden Branden    
1 AZ Maria Middelares,Gent,Belgium
2 Sint Vincentius Ziekenhuis,Deinze,Belgium
3 OLV Ziekenhuis,Aalst,Belgium
4 AZ Maria Middelares,Gent,Belg

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing